10.1099/0022-1317-51-4-344
10.1128/AAC.48.9.3291-3297.2004
10.1128/IAI.72.10.6023-6031.2004
10.1128/AAC.47.11.3657-3659.2003
10.1128/AAC.46.11.3591-3596.2002
10.1016/S0076-6879(99)10050-8
10.1099/00222615-48-7-671
10.1093/infdis/167.5.1247
10.1016/S0966-842X(99)01556-5
Brown, A. J. P. 2002. Morphogenetic signaling pathways in Candida albicans, p. 95-106. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
10.1177/10454411990100030701
10.1128/AAC.49.2.584-589.2005
10.1128/MMBR.62.1.130-180.1998
10.1128/JB.183.18.5385-5394.2001
10.1177/00220345010800031101
10.1146/annurev.mi.41.100187.002251
10.1146/annurev.mi.49.100195.003431
10.1126/science.284.5418.1318
10.1016/S0966-842X(02)00002-1
Douglas, L. J. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol.19:139-143.
10.1128/EC.3.2.536-545.2004
10.1080/1120009X.1997.12113186
10.1016/S1369-5274(02)00338-7
Gristina, A. G., Y. Shibata, G. Giridhar, A. Kreger, and Q. N. Myrvik. 1994. The glycocalyx, biofilm, microbes, and resistant infection. Semin. Arthroplasty5:160-170.
10.1080/02681219680000721
10.1080/02681219680000231
10.1099/00222615-47-3-253
10.1128/iai.62.3.915-921.1994
10.1128/JCM.36.5.1450-1452.1998
10.1111/j.1365-2958.2004.04349.x
10.1128/AEM.67.7.2982-2992.2001
Hoyle, B. D., J. Jass, and J. W. Costerton. 1990. The biofilm glycocalyx as a resistance factor. J. Antimicrob. Chemother.26:1-5.
10.1111/j.1365-2958.2004.04185.x
10.1016/S1369-5274(02)00325-9
10.1128/CMR.17.2.255-267.2004
10.1128/EC.3.4.1062-1065.2004
10.1128/IAI.70.2.878-888.2002
10.1128/AAC.46.6.1773-1780.2002
Kuhn, D. M., and M. A. Ghannoum. 2004. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs5:186-197.
10.1016/S1369-5274(02)00371-5
10.1111/j.0909-8836.2003.00084.x
10.1128/AAC.45.4.999-1007.2001
10.1128/AAC.46.11.3499-3505.2002
10.1128/AAC.46.4.1153-1155.2002
10.1128/EC.2.6.1266-1273.2003
10.1128/AAC.48.9.3358-3366.2004
10.1146/annurev.micro.55.1.165
10.1128/IAI.71.8.4333-4340.2003
National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards Wayne Pa.
10.1146/annurev.micro.54.1.49
10.1128/AAC.47.11.3580-3585.2003
10.1128/AEM.68.11.5459-5463.2002
10.1016/j.tripleo.2003.04.002
10.1128/JCM.39.9.3234-3240.2001
10.1128/AAC.45.9.2475-2479.2001
10.1128/AAC.46.11.3634-3636.2002
10.1111/j.1574-6968.2002.tb11330.x
Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol.18:163-170.
Ramage, G., B. L. Wickes, and J. L. Lopez-Ribot. 2001. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab.20:42-44.
Sbarbati, A., V. Fanos, P. Bernardi, and L. Tato. 2001. Rapid diagnosis of fungal infection of intravascular catheters in newborns by scanning electron microscopy. Scanning23:376-378.
10.1128/AAC.48.5.1727-1732.2004
10.1016/S0167-7012(01)00268-8
10.1007/s10096-002-0822-1
10.1001/archinte.1988.00380120094019
10.1046/j.1524-4733.2002.51108.x
